News | July 06, 2022
StimLabs announces new placental membrane-based product ‘Enverse’
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
Krsnaa Diagnostics now has its footprints in Delhi.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
The settlement and dismissal resolves all claims between the parties
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
